lifestyle.careersavvy.co.uk

Author: ELI LILLY AND COMPANY

Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama

December 10, 2025
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition

December 9, 2025
Lilly declares first-quarter 2026 dividend

December 8, 2025
Carolyn Bertozzi returns to Lilly board of directors

December 8, 2025
Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting

November 26, 2025
Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium

November 26, 2025
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth

November 14, 2025
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

November 11, 2025
Lilly’s selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight

November 9, 2025
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide

November 5, 2025